3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
14
Breast Neoplasms
3
Metastatic Castration-resistant Prostate Cancer
2
Carcinoma, Non-Small-Cell Lung
2
Prostate Cancer Metastatic to Bone
1
Prostate Adenocarcinoma
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Lung Neoplasms
1
Hormone Refractory Prostate Cancer
1
Bone Metastases
1
Interventions
radium Ra 223 dichloride
1
Everolimus
1
Denosumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Hormone Refractory Prostate Cancer
×
radium Ra 223 dichloride
×
Clear all
NCT00699751
2026-02-23
ALSYMPCA
Bayer
Phase 3
Completed
921 enrolled
43 charts